CRVS - CIK 0001626971
Corvus Pharmaceuticals, Inc. has filed 570 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (219 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-06-06 | 2025-06-04 |
| Major company event | 8-K | 2025-06-04 | 2025-06-04 |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| SCHEDULE 13D/A | - | 2025-05-14 | - |
| Insider trade | 4 | 2025-05-09 | 2025-05-07 |
| Quarterly report | 10-Q | 2025-05-08 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Employee stock plan | S-8 | 2025-05-08 | - |
| SCHEDULE 13D/A | - | 2025-05-01 | - |
| Proxy materials | DEFA14A | 2025-04-25 | - |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-06-12 |
| Insider trade | 4 | 2025-04-09 | 2025-04-08 |
| New insider ownership | 3 | 2025-04-09 | 2025-04-08 |
| Major company event | 8-K | 2025-04-09 | 2025-04-08 |
| Annual report | 10-K | 2025-03-25 | 2024-12-31 |
| Major company event | 8-K | 2025-03-25 | 2025-03-25 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-13 | - |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Insider trade | 4 | 2024-12-23 | 2024-12-20 |
| Insider trade | 4 | 2024-12-23 | 2024-12-20 |
| Insider trade | 4 | 2024-12-23 | 2024-12-20 |
| Insider trade | 4 | 2024-12-23 | 2024-12-20 |
| Major company event | 8-K | 2024-12-18 | 2024-12-18 |
| Quarterly report | 10-Q | 2024-11-12 | 2024-09-30 |
| Major company event | 8-K | 2024-11-12 | 2024-11-12 |
| Major company event | 8-K | 2024-10-23 | 2024-10-22 |
| EFFECT | - | 2024-08-15 | - |
| Company correspondence | CORRESP | 2024-08-13 | - |
| SEC correspondence | UPLOAD | 2024-08-13 | - |
| Quarterly report | 10-Q | 2024-08-06 | 2024-06-30 |
| Securities registration | S-3 | 2024-08-06 | - |
| Major company event | 8-K | 2024-08-06 | 2024-08-06 |
| Passive ownership stake (update) | SC 13G/A | 2024-08-01 | - |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Major company event | 8-K | 2024-06-14 | 2024-06-13 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Passive ownership stake (update) | SC 13G/A | 2024-05-13 | - |
| Passive ownership stake | SC 13G | 2024-05-09 | - |
| Insider trade | 4 | 2024-05-08 | 2024-05-06 |
| Insider trade | 4 | 2024-05-08 | 2024-05-06 |
| Activist ownership stake (update) | SC 13D/A | 2024-05-08 | - |
| Insider trade | 4 | 2024-05-07 | 2024-05-06 |
| Insider trade | 4 | 2024-05-07 | 2024-05-06 |
| Employee stock plan | S-8 | 2024-05-07 | - |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |